Combination of OipA, BabA, and SabA as candidate biomarkers for predicting Helicobacter pylori-related gastric cancer
暂无分享,去创建一个
Po-Chung Chen | J. Wu | Yu-Lin Su | Po-Chung Chen | Jiunn-Jong Wu | Jyh-Chin Yang | Lu-Ping Chow | Chien-Sheng Chen | Yu-Lin Su | L. Chow | Chien-Sheng Chen | Hsiang-Ling Huang | Bo-Shih Huang | Hong-Long Wang | Pin-Hsin Lin | Meng-Shu Chieh | Jyh-Chin Yang | Hong-Long Wang | Hsiang-Ling Huang | Bo-Shih Huang | P. Lin | Meng-Shu Chieh | B. Huang
[1] G. Rieder,et al. Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis , 1997, Infection and immunity.
[2] R. Rappuoli,et al. Helicobacter pylori virulence and genetic geography. , 1999, Science.
[3] A. Mohammadzadeh,et al. The study of the oipA and dupA genes in Helicobacter pylori strains and their relationship with different gastroduodenal diseases , 2015, Gastroenterology and hepatology from bed to bench.
[4] Y. Yamaoka. Mechanisms of disease: Helicobacter pylori virulence factors , 2010, Nature Reviews Gastroenterology &Hepatology.
[5] R. Haas,et al. Outer Membrane Protein Expression Profile in Helicobacter pylori Clinical Isolates , 2009, Infection and Immunity.
[6] V. Y. Miendje Deyi,et al. Vacuolating Cytotoxin Genotypes Are Strong Markers of Gastric Cancer and Duodenal Ulcer-Associated Helicobacter pylori Strains: a Matched Case-Control Study , 2014, Journal of Clinical Microbiology.
[7] C. Josenhans,et al. Helicobacter pylori evolution and phenotypic diversification in a changing host , 2007, Nature Reviews Microbiology.
[8] Manuel Fuentes,et al. Analysis of autoantibody profiles in osteoarthritis using comprehensive protein array concepts. , 2014, Journal of proteome research.
[9] D. Graham,et al. Helicobacter pylori outer membrane proteins and gastroduodenal disease , 2005, Gut.
[10] D. Graham,et al. Duodenal ulcer promoting gene of Helicobacter pylori. , 2005, Gastroenterology.
[11] Y. Yamaoka,et al. Systematic review and meta-analysis: the relationship between the Helicobacter pylori dupA gene and clinical outcomes , 2010, Gut pathogens.
[12] Yuan Yuan,et al. Association of Helicobacter pylori babA2 with peptic ulcer disease and gastric cancer. , 2013, World journal of gastroenterology.
[13] L. V. Rao,et al. Association between cag-pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes. , 2005, World journal of gastroenterology.
[14] F. Mégraud,et al. Evaluation of the Association of Nine Helicobacter pylori Virulence Factors with Strains Involved in Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma , 2004, Infection and Immunity.
[15] G. Perez-Perez,et al. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. , 2006, Clinical science.
[16] J. Atherton,et al. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. , 2006, Annual review of pathology.
[17] H. Juan,et al. Discovery of biomarkers for gastric cancer: a proteomics approach. , 2012, Journal of proteomics.
[18] S. Moss,et al. Helicobacter pylori virulence factors in gastric carcinogenesis. , 2009, Cancer letters.
[19] E. Rehnberg,et al. Interleukin-1β induced by Helicobacter pylori infection enhances mouse gastric carcinogenesis. , 2013, Cancer letters.
[20] A. Hensel,et al. Antiadhesive Properties of Arabinogalactan Protein from Ribes nigrum Seeds against Bacterial Adhesion of Helicobacter pylori , 2014, Molecules.
[21] H. Brenner,et al. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. , 2009, Cancer research.
[22] T. H. Wang,et al. Helicobacter pylori infection in early and advanced gastric adenocarcinoma: a seroprevalence study in 143 Taiwanese patients. , 1993, Hepato-gastroenterology.
[23] R. Peek,et al. Role of innate immunity in Helicobacter pylori-induced gastric malignancy. , 2010, Physiological reviews.
[24] Q. Zou,et al. Outer membrane inflammatory protein A, a new virulence factor involved in the pathogenesis of Helicobacter pylori , 2014, Molecular Biology Reports.
[25] F. Di Mario,et al. Non-invasive tests in gastric diseases. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[26] D. Graham,et al. Functional and Intracellular Signaling Differences Associated with the Helicobacter pylori AlpAB Adhesin from Western and East Asian Strains* , 2007, Journal of Biological Chemistry.
[27] H. Juan,et al. Identification of 14‐3‐3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker , 2011, Proteomics.
[28] Y. Yamaoka. Increasing evidence of the role of Helicobacter pylori SabA in the pathogenesis of gastroduodenal disease. , 2008, Journal of infection in developing countries.
[29] J. Wu,et al. Interaction Between Host Gastric Sialyl-Lewis X and H. pylori SabA Enhances H. pylori Density in Patients Lacking Gastric Lewis B Antigen , 2006, The American Journal of Gastroenterology.
[30] T. Testerman,et al. Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. , 2014, World journal of gastroenterology.
[31] S. Wessler,et al. The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis , 2013, Cell Communication and Signaling.
[32] Yuan Yuan,et al. Association of presence/absence and on/off patterns of Helicobacter pylori oipA gene with peptic ulcer disease and gastric cancer risks: a meta-analysis , 2013, BMC Infectious Diseases.
[33] K. Klaamas,et al. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting , 1996, International journal of cancer.
[34] T. Meyer,et al. Naturally acquired human immune responses againstHelicobacter pylori and implications for vaccine development , 1999, Gut.
[35] A. Scaloni,et al. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[36] J. Pappo,et al. The immune response against Helicobacter pylori--a direct linkage to the development of gastroduodenal disease. , 2000, Microbes and infection.
[37] C. Prinz,et al. Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. , 2006, The Journal of infectious diseases.
[38] Xiaoqun Dong,et al. Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer , 2014, Scientific Reports.
[39] Yi-Wen Chen,et al. Antibody Profiling of Bipolar Disorder Using Escherichia coli Proteome Microarrays* , 2014, Molecular & Cellular Proteomics.
[40] Wei Zhao,et al. An integrated genome-wide approach to discover tumor-specific antigens as potential immunologic and clinical targets in cancer. , 2012, Cancer research.
[41] Y. Shiratori,et al. Major virulence factors, VacA and CagA, are commonly positive inHelicobacter pylori isolates in Japan , 1998, Gut.
[42] Likun Du,et al. Expression of Helicobacter pylori Virulence Factors and Associated Expression Profiles of Inflammatory Genes in the Human Gastric Mucosa , 2007, Infection and Immunity.
[43] Jaw-Town Lin,et al. Proteomic identification of biomarkers related to Helicobacter pylori‐associated gastroduodenal disease: Challenges and opportunities , 2008, Journal of gastroenterology and hepatology.
[44] K. Chayama,et al. Advanced Method for Evaluation of Gastric Cancer Risk By Serum Markers: Determination of True Low‐Risk Subjects for Gastric Neoplasm , 2014, Helicobacter.
[45] T. Azuma,et al. Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer. , 2013, World journal of gastroenterology.
[46] Keith T. Wilson,et al. Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk , 2010, Clinical Microbiology Reviews.
[47] M. Rugge,et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. , 2008, Gastroenterology.
[48] Yuan Yuan,et al. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers , 2014, Scandinavian journal of gastroenterology.
[49] C. Hamashima. Current issues and future perspectives of gastric cancer screening. , 2014, World journal of gastroenterology.
[50] D. Graham,et al. Helicobacter pylori virulence and cancer pathogenesis. , 2014, Future oncology.
[51] Hwee Tong Tan,et al. Serum autoantibodies as biomarkers for early cancer detection , 2009, The FEBS journal.
[52] G. Wallstrom,et al. A versatile protein microarray platform enabling antibody profiling against denatured proteins , 2013, Proteomics. Clinical applications.
[53] Y. Yamaoka,et al. Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. , 2010, Future microbiology.
[54] R. Peek,et al. Helicobacter pylori: gastric cancer and beyond , 2010, Nature Reviews Cancer.
[55] M. Pawlita,et al. A CagA‐independent cluster of antigens related to the risk of noncardia gastric cancer: Associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology , 2014, International journal of cancer.
[56] N. Sasaki,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[57] Ding-Shinn Chen,et al. Comparative Immunoproteomics of Identification and Characterization of Virulence Factors from Helicobacter pylori Related to Gastric Cancer * S , 2006, Molecular & Cellular Proteomics.
[58] Chun-Hao Huang,et al. Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases. , 2014, World journal of gastroenterology.
[59] M. Gerhard,et al. H. pylori Virulence Factors: Influence on Immune System and Pathology , 2014, Mediators of inflammation.
[60] K. Matsuo,et al. Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer , 2012, Gastric Cancer.